Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)

Shanghai Pharmaceuticals Holding Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	33,823	30,518	27,401	22,390	22,354	18,200
Trading Asset Securities	8,563	10,152	9,614	-	-	-
Cash & Short-Term Investments	42,385	40,670	37,015	22,390	22,354	18,200
Cash Growth	4.22%	9.87%	65.32%	0.16%	22.83%	-5.95%
Accounts Receivable	86,054	77,163	70,187	61,006	55,522	49,801
Other Receivables	3,240	2,373	1,957	1,786	1,343	1,518
Receivables	89,294	79,536	72,144	62,791	56,865	51,319
Inventory	37,576	36,623	34,460	27,104	24,088	24,877
Other Current Assets	4,532	5,605	5,894	4,209	4,255	3,695
Total Current Assets	173,788	162,434	149,513	116,494	107,563	98,092
Property, Plant & Equipment	18,726	18,302	16,550	15,793	14,626	13,128
Long-Term Investments	10,381	10,603	11,477	10,836	7,663	5,432
Goodwill	11,408	11,393	11,336	11,239	11,342	10,790
Other Intangible Assets	5,754	6,070	6,263	6,049	5,195	3,930
Long-Term Deferred Tax Assets	1,805	1,717	1,535	1,368	1,359	1,223
Long-Term Deferred Charges	220.2	310.51	342.61	259.23	639.15	606.39
Other Long-Term Assets	1,660	1,143	1,119	1,397	797.64	3,825
Total Assets	223,741	211,973	198,135	163,436	149,186	137,026
Accounts Payable	61,688	54,632	51,566	41,995	37,792	36,872
Accrued Expenses	1,591	10,638	9,574	7,985	6,816	5,405
Short-Term Debt	45,017	41,612	33,811	31,592	25,158	23,139
Current Portion of Long-Term Debt	1,927	2,366	2,649	33.44	8,311	624.86
Current Portion of Leases	-	596.67	580.68	545.04	574.57	560.87
Current Income Taxes Payable	952.11	809.8	781.36	721.16	682.45	716.99
Current Unearned Revenue	1,442	1,971	2,243	1,311	1,311	1,534
Other Current Liabilities	16,916	9,747	9,487	7,642	7,488	5,755
Total Current Liabilities	129,532	122,372	110,691	91,824	88,133	74,608
Long-Term Debt	7,690	5,786	6,260	7,158	1,184	9,134
Long-Term Leases	1,619	1,550	1,302	1,434	1,501	1,156
Long-Term Unearned Revenue	589.68	633.48	534.58	2,349	2,224	1,279
Long-Term Deferred Tax Liabilities	876.71	1,016	1,049	998.77	832.38	809.6
Other Long-Term Liabilities	251.34	250.14	257.26	566.09	570.39	654.6
Total Liabilities	140,584	131,646	120,132	104,369	94,445	87,640
Common Stock	3,705	3,703	3,698	2,842	2,842	2,842
Additional Paid-In Capital	-	29,188	29,098	16,071	15,898	15,721
Retained Earnings	38,368	36,129	34,639	30,591	26,880	23,639
Comprehensive Income & Other	28,793	-496.09	-371.32	-144.39	-265.41	-542.23
Total Common Equity	70,866	68,524	67,063	49,359	45,355	41,659
Minority Interest	12,292	11,802	10,939	9,707	9,386	7,727
Shareholders' Equity	83,158	80,326	78,002	59,066	54,741	49,386
Total Liabilities & Equity	223,741	211,973	198,135	163,436	149,186	137,026
Total Debt	56,253	51,911	44,602	40,762	36,728	34,614
Net Cash (Debt)	-13,867	-11,241	-7,587	-18,372	-14,374	-16,415
Net Cash Per Share	-3.72	-3.04	-2.18	-6.46	-5.06	-5.78
Filing Date Shares Outstanding	3,705	3,703	3,698	2,842	2,842	2,842
Total Common Shares Outstanding	3,705	3,703	3,698	2,842	2,842	2,842
Working Capital	44,256	40,062	38,822	24,670	19,430	23,484
Book Value Per Share	19.13	18.50	18.14	17.37	15.96	14.66
Tangible Book Value	53,704	51,061	49,464	32,071	28,817	26,939
Tangible Book Value Per Share	14.50	13.79	13.38	11.28	10.14	9.48
Buildings	-	11,460	10,941	9,698	9,351	8,480
Machinery	-	10,035	9,054	8,203	7,743	6,799
Construction In Progress	-	3,570	2,777	2,914	1,737	1,650

Source: S&P Capital IQ. Standard template. Financial Sources.